derived leukemic cells as on B-cell derived cells7) is also dealt with as an extension of this study.
The biological and biochemical activity of actinobolin and bactobolin was determined in various assay systems with the results summarized in Table 1 . With respect to inhibition of growth Otherwise (medium, cell density, etc.) conducted as in the Fig. 1 experiment. e) An assay mixture consisted of 1 .6 ml of a suspension of 4 x 104 cells of L-1210 in Eagle's MEM supplemented with 5 % calf serum (growth medium) and 0.4 ml of phosphate buffered saline (PBS) dissolving the test compound at the desired concentration.
After cultivation at 37°C for 2 days, cells were washed with PBS and the amount of cell protein was determined by LOWRY'S method. Triplicate runs were averaged. (Table 1 , b) suggesting that bactobolin, like actinobolin, acts as an inhibitor of protein synthesis. This possibility was confirmed by a separate experiment in which the effect of bactobolin on the incorporation of radioactive leucine, thymidine and uridine into cellular macromolecules was determined. As Fig. 1 shows, the incorporation of leucine only was sensitive to bactobolin indicating that the antibiotic shares a common mode of action with actinobolin, although their effective concentrations differed considerably. With an assay system of tumor cells (Table 1 , c), the difference in the effectiveness of the two antibiotics appeared much greater; the growth-inhibitory activity, or cytotoxicity of bactobolin to L-1210 cells, cultured in vitro, was about 900 times that of actinobolin. The difference in the direct effect of the two antibiotics on the tumor cells seems to account for the marked difference in their antitumor activity previously determined with various experimental tumors1,3, 4) .
Considering their toxic effects in mice, i.e., LD5a values of 800 mg/ kg8} and 6.25 N 12.5 mg/kg1) for actinobolin and bactobolin, respectively, the chemotherapeutic index of bactobolin in mice inoculated with L-1210 should be several-fold greater than that of actinobolin. Next we asked how the marked difference between the two antibiotics in their cytotoxicity to L-1210 cells is exerted. The simplest answer would be that the difference was solely attributable to different sensitivities of the tumor cell ribosomes to the two antibiotics. In other words, the eukaryotic ribosomes possibly recognize and respond to the structural difference between the two antibiotics more sharply than the prokaryotic ribosomes do. To test this possibility, their effects on incorporation of 14C-leucine into proteins in L-1210 cells were determined. The result ( Table 1 , d) showed that bactobolin was 570 times as inhibitory as actinobolin, the ratio being fairly close to that of cytotoxicity, indicating that the difference in the affinity of the protein synthesizing system, probably ribosomes, is likely to be the only cause of the difference in the cytotoxicity. Using cell suspensions of mouse leukemia L-1210, an experi- Fig. 1 . Effect of bactobolin on macromolecular synthesis in E. coli K12. Cells were grown in a casein hydrolysate/glucose medium (CG medium).
At a growth stage of 0.1 A600 nm, the culture received 0.1 mhi deoxyadenosine and was divided into six 0.9 ml portions which made up three sets of two tubes each. To one tube of each set, 50 µl of an aqueous solution of bactobolin was added to make the final concentration of 1.64 x 10-~ M (s). To the other tube, 50 ,ul of water was added (O). All the tubes were warmed at 37°C for 7 minutes, and labeled by the addition of 50 ,ul solution of each radioactive precursor; 0.5 uCi of [14C]thymidine for Set 1, 0.05 itCi of [14C]uridine for Set 2, and 1.25 FtCi of [14C]leucine for Set 3. The assay mixtures were incubated at 37°C. At the times indicated, 0.1 ml samples were withdrawn onto Whatman 3 MM filter discs, treated with cold 5 % trichloroacetic acid and processed Radioactivitiy in the acid insoluble materials (acid-insoluble radioactivity) was determined in a toluene-based scintillator. Labeling time (minutes) ment analogous to the Fig. 1 experiment was conducted. The result showed that bactobolin inhibited the incorporation of 14C-leucine more rapidly and strongly than it inhibited the incorporation of 14C-adenosine (data not shown). However, the type of inhibition was not as specific to protein synthesis as it was with E, coil (Fig. 1) , probably because of a closer interdependence between protein and nucleic acid synthesis in mammalian cells6' . For further confirmation of the specific inhibition of protein synthesis by bactobolin, the effects of the two antibiotics on a typical eukaryotic cell-free protein synthesizing system consisting of rabbit reticulocyte ribosomes, haemoglobin mRNA, et cetera, were compared. The 1000-fold difference in their inhibitory strength (Table 1 , e) supports the above hypothesis, namely, cytotoxicity is a direct reflection of the sensitivity of the ribosomes. It should be noted that both antibiotics inhibited more strongly protein synthesis in intact cells of L-1210 than haemoglobin synthesis by the cellfree system (compare the ID50 values of d with those of e, Table 1 ). The result could be interpreted as indicating that these antibiotics readily permeate the animal cells. All these studies led to the following conclusions: (1) Bactobolin, as well as actinobolin, inhibits growth of either bacterial or mammalian cells by acting as an inhibitor of protein synthesis. (2) Bactobolin is stronger than actinobolin in inhibiting growth of cells of E. coli and of mouse leukemia L-1210 by factors of 21 and 900, respectively, the difference being well correlated with the different affinities of the protein synthesizing systems, probably ribosomes, of these cells.
To support the recent finding that T-cell derived leukemic cells were less sensitive to bactobolin than those derived from B-cells, the effect of the antibiotic on protein synthesis in intact cells of MOLT 4F (T-type)* and RPMI 1788 (B-type)* was determined for comparison. The experimental procedure was similar to that of Exp. d, Table 1 . ID50 of bactobolin for the T-type and B-type cells was 2.1 x 10 -SM and 1.05 x 10-6M, respectively, indicating that the sensitivity of the protein synthesizing systems of these cells is responsible, at least in part, for the difference in the response of the cells to the antibiotic. The question as to whether the difference depends on modification of permeability, or ribosomes, or something else, remains to be answered.
